# Fraser Kearney Capital Corp.

> Fraser Kearney Capital Corp. is a VC fund backing Health Care and Medical. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Toronto, Canada
- Total investments: 2
- Last investment: Jul 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/fraser-kearney-capital-corp./

Fraser Kearney Capital Corp. is a VC fund in Toronto focused on Health Care and Medical. It is a Executive Office.

## Contacts

5 contacts available for Fraser Kearney Capital Corp.. Shizune tracks 1 team members at Fraser Kearney Capital Corp.. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fraser-kearney-capital-corp?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Medical | 1 | 50% |
| Software | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Convertible Note | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| John Francis | Managing Director | 1 | https://shizune.co/investors/profile/john-francis-2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oncoustics AI | Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M | Seed | Jul 21, 2022 |  |
| ManagingLife | ManagingLife's industry-leading digital health solution, Manage My Pain, helps patients and doctors better measure, monitor, and manage pain. Manage My Pain is a digital pain treatment companion with clinical validation and has one of the largest datasets that includes over 5M patient-reported pain outcomes from over 125,000 users from 130countries. Built into Manage My Pain is Solace, a first-of-its-kind AI companion that delivers real-time, evidence-based pain psychology support - which showed significant improvements in people who interacted with it for just 30 minutes.Manage My Pain is the leading pain app on the market, and has been licensed by hospitals and insurers across North America. Manage My Pain improves patient outcomes, reduces medical spend, and shortens disability claims. | $670K | Convertible Note | Dec 31, 2019 |  |

2 of 2 investments shown.

## Co-investors
- [Creative Ventures](https://shizune.co/investors/profile/creative-ventures) — VC Fund, 2 deals together
- [Bryker](https://shizune.co/investors/profile/bryker) — VC Fund, 1 deal together
- [Elkland Capital](https://shizune.co/investors/profile/elkland-capital) — VC Fund, 1 deal together
- [NorthSpring Capital Partners](https://shizune.co/investors/profile/northspring-capital-partners) — VC Fund, 1 deal together
- [Pallasite Ventures](https://shizune.co/investors/profile/pallasite-ventures) — VC Fund, 1 deal together
- [Pool Global Partners](https://shizune.co/investors/profile/pool-global-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Fraser Kearney Capital Corp. invest in?

Fraser Kearney Capital Corp. invests primarily in Health Care, Medical and Software startups, most often at Seed and Convertible Note stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Fraser Kearney Capital Corp.?

Public channels for Fraser Kearney Capital Corp. include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fraser Kearney Capital Corp.?

The team at Fraser Kearney Capital Corp. includes John Francis (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co